Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
Heartflow (Nasdaq: HTFL) said management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 p.m. PT / 3:30 p.m. ET. The session will be available live and archived on the company's Investor Relations website.
Investors can access the webcast and archived replay at https://ir.heartflow.com.
Heartflow (Nasdaq: HTFL) ha dichiarato che la direzione parteciperà a un colloquio informale al Piper Sandler 37th Annual Healthcare Conference il mercoledì 3 dicembre 2025 alle 12:30 PT / 15:30 ET. La sessione sarà disponibile in diretta e archiviata sul sito Investor Relations dell'azienda.
Gli investitori possono accedere al webcast e alla riproduzione archiviata su https://ir.heartflow.com.
Heartflow (Nasdaq: HTFL) dijo que la dirección participará en una charla informal en la Piper Sandler 37th Annual Healthcare Conference el miércoles 3 de diciembre de 2025 a las 12:30 p.m. PT / 3:30 p.m. ET. La sesión estará disponible en vivo y archivada en el sitio de Relaciones con Inversores de la empresa.
Los inversores pueden acceder a la transmisión en directo y a la reproducción archivada en https://ir.heartflow.com.
Heartflow (나스닥: HTFL)은 경영진이 Piper Sandler 37th Annual Healthcare Conference에서 화롯대 대화를 할 예정이며 2025년 12월 3일 수요일 오후 12:30 PT / 오후 3:30 ET에 개최된다고 밝혔다. 세션은 회사의 투자자 관계 웹사이트에서 생중계 및 보관본으로 이용 가능하다.
투자자들은 https://ir.heartflow.com에서 webcast 및 보관 재생을 이용할 수 있다.
Heartflow (Nasdaq : HTFL) a déclaré que la direction participera à une discussion informelle lors de la Conférence annuelle Piper Sandler sur les soins de santé n°37 le mercredi 3 décembre 2025 à 12h30 PT / 15h30 ET. La séance sera disponible en direct et en archivage sur le site des Relations Investisseurs de l'entreprise.
Les investisseurs peuvent accéder à la diffusion et à la rediffusion archivÉe sur https://ir.heartflow.com.
Heartflow (Nasdaq: HTFL) sagte, das Management werde an einem Fireside-Chat bei der Piper Sandler 37th Annual Healthcare Conference am Mittwoch, dem 3. Dezember 2025 um 12:30 Uhr PT / 15:30 Uhr ET teilnehmen. Die Sitzung wird live und archiviert auf der Investor Relations-Website des Unternehmens verfügbar sein.
Investoren können den Webcast und die archivierte Wiedergabe unter https://ir.heartflow.com aufrufen.
Heartflow (ناسداك: HTFL) قالت الإدارة إنها ستشارك في جلسة حوارية fireside خلال مؤتمر Piper Sandler الصحي السنوي الـ37 يوم الأربعاء 3 ديسمبر 2025 في الساعة 12:30 ظهرًا بتوقيت المحيط الهادئ / 3:30 عصرًا بتوقيت شرق الولايات المتحدة. ستكون الجلسة متاحة مباشرة ومؤرشفة على موقع العلاقات مع المستثمرين الخاص بالشركة.
يمكن للمستثمرين الوصول إلى البث المباشر وإعادة العرض المؤرشَف على https://ir.heartflow.com.
- None.
- None.
MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference. The fireside chat will take place on Wednesday, December 3, 2025, at 12:30 p.m. PT / 3:30 p.m. ET.
A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com.
About Heartflow’s Technology and Research
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide. Key benefits include:
- Proprietary data pipeline: Built from more than 110 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible insights across diverse patient populations.
- Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed
96% . - Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
- Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.
About Heartflow, Inc.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.
Investor Contact
Nick Laudico
nlaudico@heartflow.com
Media Contact
Elliot Levy
elevy@heartflow.com
FAQ
When will Heartflow (HTFL) present at the Piper Sandler 37th Annual Healthcare Conference?
How can investors watch Heartflow's (HTFL) fireside chat on December 3, 2025?
What topics will Heartflow (HTFL) management likely cover at the Piper Sandler conference?
Is the Heartflow (HTFL) webcast free and publicly accessible?
Will Heartflow (HTFL) provide a replay if I cannot attend the December 3, 2025 session live?
